Literature DB >> 11696980

Identification of the human homologue of the early-growth response gene Snk, encoding a serum-inducible kinase.

K Liby1, H Wu, B Ouyang, S Wu, J Chen, W Dai.   

Abstract

Murine serum inducible kinase (mSnk) was recently cloned and characterized as an early-growth response gene involved in cell proliferation. Here we report the isolation and characterization of its human homologue, named hSnk. Sequence comparison shows that hSnk is highly conserved and its deduced protein sequence shares a significant amino acid identity with mSnk and rSnk proteins, as well as with other polo family kinase gene products. A survey of hSnk expression reveals that while a wide variety of human tissues express a low to moderate level of hSnk transcripts, fetal tissues, testis, and spleen express the most abundant hSnk transcripts. In addition, serum stimulation rapidly induces hSnk expression in fibroblast cells, reaching the peak level of induction within one hour post treatment. Considering that Plk and Prk, two other known human polo-family kinases, control cell cycle checkpoint and cell cycle progression, our current observations suggest that hSnk may also play an important role in cells undergoing rapid cell division or having a high mitotic index.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696980     DOI: 10.3109/10425170109041337

Source DB:  PubMed          Journal:  DNA Seq        ISSN: 1026-7913


  12 in total

1.  Sputa nerve growth factor forms a preferable substitute to mouse 7S-beta nerve growth factor.

Authors:  Dawn C-I Koh; A Armugam; K Jeyaseelan
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 2.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

3.  Involvement of polo-like kinase 1 (Plk1) in mitotic arrest by inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-ribosomal S6 kinase 1 (MEK-ERK-RSK1) cascade.

Authors:  Ran Li; Dian-Fu Chen; Rong Zhou; Sheng-Nan Jia; Jin-Shu Yang; James S Clegg; Wei-Jun Yang
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

Review 4.  Polo-box domain: a versatile mediator of polo-like kinase function.

Authors:  Jung-Eun Park; Nak-Kyun Soung; Yoshikazu Johmura; Young H Kang; Chenzhong Liao; Kyung H Lee; Chi Hoon Park; Marc C Nicklaus; Kyung S Lee
Journal:  Cell Mol Life Sci       Date:  2010-02-11       Impact factor: 9.261

5.  Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics.

Authors:  Yang Gao; Elena B Kabotyanski; Jonathan H Shepherd; Elizabeth Villegas; Deanna Acosta; Clark Hamor; Tingting Sun; Celina Montmeyor-Garcia; Xiaping He; Lacey E Dobrolecki; Thomas F Westbrook; Michael T Lewis; Susan G Hilsenbeck; Xiang H-F Zhang; Charles M Perou; Jeffrey M Rosen
Journal:  Cancer Res Commun       Date:  2021-12-27

6.  The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.

Authors:  Elizabeth M Matthew; Lori S Hart; Aristotelis Astrinidis; Arunasalam Navaraj; Nathan G Dolloff; David T Dicker; Elizabeth P Henske; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2009-12-15       Impact factor: 4.534

7.  Plk2 regulates mitotic spindle orientation and mammary gland development.

Authors:  Elizabeth Villegas; Elena B Kabotyanski; Amy N Shore; Chad J Creighton; Thomas F Westbrook; Jeffrey M Rosen
Journal:  Development       Date:  2014-03-05       Impact factor: 6.868

8.  The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus.

Authors:  Zdenek Andrysik; William Z Bernstein; Li Deng; David L Myer; Ya-Qin Li; Jay A Tischfield; Peter J Stambrook; El Mustapha Bahassi
Journal:  Nucleic Acids Res       Date:  2010-01-25       Impact factor: 16.971

Review 9.  From Plk1 to Plk5: functional evolution of polo-like kinases.

Authors:  Guillermo de Cárcer; Gerard Manning; Marcos Malumbres
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

10.  Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile.

Authors:  Sisi Deng; Xiaoli Lu; Zhi Zhang; Rui Meng; Mi Li; Shilin Xia
Journal:  J Cell Mol Med       Date:  2021-06-02       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.